The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-chloro-N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acetamide ID: ALA4763652
PubChem CID: 162661877
Max Phase: Preclinical
Molecular Formula: C22H21Cl3N4O4
Molecular Weight: 511.79
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CCl)nc2)c1Cl
Standard InChI: InChI=1S/C22H21Cl3N4O4/c1-12-5-4-6-15(28-18(30)8-23)21(12)29-22-26-9-13(10-27-22)33-11-14-19(24)16(31-2)7-17(32-3)20(14)25/h4-7,9-10H,8,11H2,1-3H3,(H,28,30)(H,26,27,29)
Standard InChI Key: NYHIQYJMJPLYCG-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
31.4446 -12.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4433 -13.5066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1582 -13.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8746 -13.5061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8718 -12.6755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1564 -12.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1539 -11.4414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8671 -11.0268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5808 -11.4395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2935 -11.0256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2915 -10.1997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5708 -9.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8610 -10.2058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0042 -9.7841 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.7204 -10.1935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4331 -9.7780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1465 -10.1886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8588 -9.7736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8557 -8.9477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1343 -8.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4251 -8.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5748 -10.1834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1279 -7.7135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.8391 -7.2955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2877 -9.7682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1488 -11.0136 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
35.7070 -8.5497 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.5847 -12.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7300 -12.2669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0156 -12.6796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3011 -12.2672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5866 -12.6799 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.0158 -13.5045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
11 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
20 23 1 0
23 24 1 0
22 25 1 0
17 26 1 0
21 27 1 0
5 28 1 0
1 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
30 33 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 511.79Molecular Weight (Monoisotopic): 510.0628AlogP: 5.61#Rotatable Bonds: 9Polar Surface Area: 94.60Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.73CX Basic pKa: 1.77CX LogP: 4.92CX LogD: 4.92Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.36Np Likeness Score: -0.91
References 1. Deng W,Chen X,Jiang K,Song X,Huang M,Tu ZC,Zhang Z,Lin X,Ortega R,Patterson AV,Smaill JB,Ding K,Chen S,Chen Y,Lu X. (2021) Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors., 12 (4.0): [PMID:33859803 ] [10.1021/acsmedchemlett.1c00052 ]